Perspectives About Modulating Host Immune System in Targeting SARS-CoV-2 in India

Perspectives About Modulating Host Immune System in Targeting SARS-CoV-2 in India

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of coronavirus induced disease-2019 (COVID-19), is a type of common cold virus responsible for a global pandemic which requires immediate measures for its containment. India has the world’s largest population aged betw...

Full description

Bibliographic Details
Main Authors:	Sreyashi Majumdar, Rohit Verma, Avishek Saha, Parthasarathi Bhattacharyya, Pradipta Maji, Milan Surjit, Manikuntala Kundu, Joyoti Basu, Sudipto Saha
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Genetics
Subjects:	SARS-CoV-2 genetic variations host immuno-modulation repurposed drugs vaccines medicinal plants
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2021.637362/full

Similar Items

SARS-CoV-2: Virology and Drug Repurposing Approaches
by: Ratika Rahmasari, et al.
Published: (2020-07-01)

Unleashing immuno-mass spectrometry superpowers to detect SARS-CoV-2
by: Jean Armengaud
Published: (2021-07-01)

RNA-Protein Interaction Analysis of SARS-CoV-2 5′ and 3′ Untranslated Regions Reveals a Role of Lysosome-Associated Membrane Protein-2a during Viral Infection
by: Rohit Verma, et al.
Published: (2021-08-01)

Ligand-Based and Structured-Based In Silico Repurposing Approaches to Predict Inhibitors of SARS-CoV-2 Mpro Protein
by: Alfredo Juárez-Saldívar, et al.
Published: (2020-11-01)

Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
by: Tiziana Ginex, et al.
Published: (2021-04-01)

Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review
by: Jennifer Santos, et al.
Published: (2020-06-01)

A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2
by: Seri Jo, et al.
Published: (2021-04-01)

Epitope based vaccine prediction for SARS-COV-2 by deploying immuno-informatics approach
by: Amit Joshi, et al.
Published: (2020-01-01)

The Combination of Bromelain and Acetylcysteine (BromAc) Synergistically Inactivates SARS-CoV-2
by: Javed Akhter, et al.
Published: (2021-03-01)

Drug Repurposing Against SARS-CoV-2: Targeting NSP16-NSP10 Interaction
by: Sefer BADAY
Published: (2021-08-01)

An Optimized High-Throughput Immuno-Plaque Assay for SARS-CoV-2
by: Alberto A. Amarilla, et al.
Published: (2021-02-01)

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
by: Canrong Wu, et al.
Published: (2020-05-01)

Identification of potential antivirals against SARS-CoV-2 using virtual screening method
by: Mohammad Rejaur Rahman, et al.
Published: (2021-01-01)

Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies
by: Amal Mahmoud, et al.
Published: (2021-09-01)

Functionalized Dendrimer Platforms as a New Forefront Arsenal Targeting SARS-CoV-2: An Opportunity
by: Serge Mignani, et al.
Published: (2021-09-01)

Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2
by: Catherine Z. Chen, et al.
Published: (2021-01-01)

Pharmacophore Modelling-Based Drug Repurposing Approaches for SARS-CoV-2 Therapeutics
by: Shailima Rampogu, et al.
Published: (2021-05-01)

Host transcriptome-guided drug repurposing for COVID-19 treatment: a meta-analysis based approach
by: Tamizhini Loganathan, et al.
Published: (2020-06-01)

In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing
by: Yogesh Kumar, et al.
Published: (2020-09-01)

An Update on Antiviral Therapy Against SARS-CoV-2: How Far Have We Come?
by: Omkar Indari, et al.
Published: (2021-03-01)

Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2
by: Kartikay Prasad, et al.
Published: (2021-01-01)

Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2
by: N.R. Jena
Published: (2021-06-01)

Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets
by: Isabella Romeo, et al.
Published: (2021-01-01)

Antiviral Properties of the NSAID Drug Naproxen Targeting the Nucleoprotein of SARS-CoV-2 Coronavirus
by: Olivier Terrier, et al.
Published: (2021-04-01)

Editorial: Molecular Studies of Covid-19 Chemistry
by: Domenica Capasso, et al.
Published: (2021-08-01)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
by: Adi Nagler, et al.
Published: (2021-06-01)

Repurposing existing drugs: identification of SARS-CoV-2 3C-like protease inhibitors
by: Wei-Chung Chiou, et al.
Published: (2021-01-01)

Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2
by: Abhinit Kumar, et al.
Published: (2021-01-01)

Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel <i>In Silico</i> Method
by: Milan Sencanski, et al.
Published: (2020-08-01)

In Vitro Assessment of the Antiviral Activity of Ketotifen, Indomethacin and Naproxen, Alone and in Combination, against SARS-CoV-2
by: Pantea Kiani, et al.
Published: (2021-03-01)

Drug Repurposing and Polypharmacology to Fight SARS-CoV-2 Through Inhibition of the Main Protease
by: Luca Pinzi, et al.
Published: (2021-02-01)

SARS-Cov-2 Interactome with Human Ghost Proteome: A Neglected World Encompassing a Wealth of Biological Data
by: Tristan Cardon, et al.
Published: (2020-12-01)

Dual targeting of 3CLpro and PLpro of SARS-CoV-2: A novel structure-based design approach to treat COVID-19
by: Sajjan Rajpoot, et al.
Published: (2021-01-01)

The polybasic insert, the RBD of the SARS-CoV-2 spike protein, and the feline coronavirus – evolved or yet to evolve
by: Anshul Budhraja, et al.
Published: (2021-03-01)

IL-32: an emerging player in the immune response network against tuberculosis?
by: Manikuntala Kundu, et al.
Published: (2006-08-01)

Applications of Transcriptomics and Proteomics for Understanding Dormancy and Resuscitation in Mycobacterium tuberculosis
by: Manikuntala Kundu, et al.
Published: (2021-03-01)

The Role of microRNAs and Long Non-Coding RNAs in the Regulation of the Immune Response to Mycobacterium tuberculosis Infection
by: Manikuntala Kundu, et al.
Published: (2021-06-01)

The study of antiviral drugs targeting SARS-CoV-2 nucleocapsid and spike proteins through large-scale compound repurposing
by: Xuqiao Hu, et al.
Published: (2021-03-01)

Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach
by: Andrea Gelemanović, et al.
Published: (2021-01-01)

Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19
by: Wen Cui, et al.
Published: (2020-12-01)

Cannot write session to /tmp/vufind_sessions/sess_ts7jtb04l39h0kd9vgraam6rjl